📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Anthem Biosciences to Host Q3FY26 Earnings Call on February 5, 2026
Anthem Biosciences Limited has issued a revised schedule for its earnings conference call to discuss the unaudited financial results for Q3 and the nine months ended December 31, 2025. The call is scheduled for Thursday, February 5, 2026, at 02:30 PM IST. This revision was necessitated by a non-functional joining link in the previous intimation. Senior management, including the MD & CEO and the CFO, will be present to discuss performance and answer questions.
Key Highlights
Earnings conference call scheduled for February 5, 2026, at 02:30 PM IST.
Focus on Unaudited Standalone and Consolidated Financial Results for Q3 and 9M FY26.
Management participants include MD & CEO Ajay Bhardwaj and CFO Gawir Baig.
Revised intimation provides corrected functional Diamond Pass registration links.
Call hosted by JM Financial Institutional Securities Limited.
💼 Action for Investors
Investors interested in the company's quarterly performance should use the revised link to join the call on February 5. No immediate action is required as this is a routine administrative update.